Aurora Drug Discovery Description
Aurora utilizes principles of quantum mechanics and thermodynamics alongside a sophisticated continuous water model to assess the solvation effects on ligand binding affinities. This methodology is significantly different from the traditional scoring functions typically employed for predicting binding affinities. By integrating entropy and aqueous electrostatic contributions directly into the computations, Aurora's algorithms yield far more precise and reliable binding free energy values. The interaction between a ligand and a protein is fundamentally defined by the binding free energy value. This free energy (F) serves as a thermodynamic measure that correlates directly with the experimentally determined inhibition constant (IC50), influenced by factors such as electrostatic interactions, quantum effects, aqueous solvation forces, and the statistical characteristics of the molecules involved. Non-additivity in F arises primarily from two key components: the electrostatic and solvation energy, and the entropy, which together contribute to the complexity of ligand-protein interactions. Understanding these contributions is essential for the accurate prediction of binding affinities in drug design and molecular biology.
Aurora Drug Discovery Alternatives
Foxit delivers a robust set of cloud-native APIs that enable organizations to automate and modernize document-driven workflows at scale. Built on flexible REST architecture, these APIs allow developers to seamlessly create, convert, extract, sign, and display documents within their own applications—improving efficiency while reducing manual processes.
The Foxit PDF Services API handles large-scale PDF processing, including conversion, extraction, optimization, and redaction. The Document Generation API streamlines the production of personalized PDFs and DOCX files using dynamic templates and live business data. The Foxit eSign API integrates secure, legally binding eSignature workflows with audit tracking and compliance capabilities. The PDF Embed API provides customizable in-app document viewing with support for annotations, forms, and secure user access.
Combined, Foxit APIs give enterprises a secure and scalable platform for digital document automation and workflow transformation.
Learn more
DbVisualizer is a universal database client for anyone who works with data, from indie developers and startups to professional teams managing complex database environments, including developers, DBAs, analysts, and data engineers working across relational and NoSQL databases.
Key features:
- SQL editor with intelligent autocomplete, visual query builders, variables, and execution tools
- AI Assistant for answering questions, explaining errors, and analyzing code
- Git integration for managing SQL scripts and team collaboration
- Customizable layouts, key bindings, and UI themes
- Favorites for frequently used scripts and database objects
- Configurable security settings for organizational requirements
Connects via JDBC to MySQL, PostgreSQL, SQL Server, Oracle, Snowflake, SQLite, Cassandra, BigQuery, and more. Runs on Windows, macOS, and Linux.
Nearly 7 million downloads, with Pro users in 150 countries, scaling from solo projects to enterprise database management.
Learn more
AutoDock
AutoDock is a comprehensive suite comprising automated docking tools that aim to forecast the binding interactions of small molecules, like substrates or potential drugs, with a receptor that has a known three-dimensional structure. Over time, this toolset has undergone various modifications and enhancements to introduce new features, alongside the development of multiple computational engines. The software currently includes two main versions: AutoDock 4 and AutoDock Vina, each serving distinct purposes. Recently, the introduction of AutoDock-GPU has provided a significantly accelerated alternative to AutoDock4, achieving docking speeds that are remarkably hundreds of times faster than the original single-CPU version. AutoDock 4 is fundamentally made up of two core components: autodock, which executes the docking of the ligand onto a series of grids that represent the target protein, and autogrid, which is responsible for generating these grids ahead of time. These atomic affinity grids are not just useful for docking purposes; they can also be visualized to aid researchers, particularly organic synthetic chemists, in crafting more effective binding agents. This visualization capability can help streamline the process of drug design significantly.
Learn more
3decision
3decision® serves as a cloud-based repository for protein structures, focusing on efficient management of structural data and offering sophisticated analytics to support teams involved in the discovery of small molecules and biologics, thereby expediting the process of structure-based drug design.
The platform consolidates and standardizes both experimental and computational protein structures sourced from publicly available databases such as RCSB PDB and AlphaFoldDB, in addition to proprietary datasets, and accommodates formats like PDBx/mmCIF and ModelCIF. This comprehensive approach guarantees seamless access to a variety of structural formats including X-Ray, NMR, cryo-EM, and modeled structures, thereby promoting collaboration and bolstering research initiatives.
In addition to its storage capabilities, 3decision® enhances each entry with valuable metadata and sequence information, which encompasses details on protein-ligand interactions, antibody annotations, and specifics about binding sites. Equipped with advanced analytical instruments, the platform is capable of pinpointing druggable sites, evaluating off-target risks, and facilitating comparisons of binding sites, which collectively transform extensive structural datasets into practical insights that can drive research forward.
Furthermore, its cloud-based architecture fosters enhanced collaboration among research teams, making it easier for scientists to share findings and insights, ultimately leading to more innovative approaches in drug discovery and development.
Learn more
Integrations
No Integrations at this time
Company Details
Company:
Aurora Fine Chemicals
Year Founded:
1990
Headquarters:
United States
Website:
aurorafinechemicals.com/drug-discovery-software.html
Media
Recommended Products
Build Agents and Models on One Platform
Gemini Enterprise Agent Platform is Google Cloud's comprehensive platform for developers to build, scale, govern, and optimize agents and models. Choose from Google's most advanced models and third-party models like Anthropic's Claude Model Family.
Product Details
Platforms
Web-Based
Customer Support
Business Hours
Online Support
Aurora Drug Discovery Features and Options
Aurora Drug Discovery User Reviews
Write a Review- Previous
- Next
